|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019046,
umls-concept:C0030705,
umls-concept:C0138741,
umls-concept:C0205103,
umls-concept:C0205265,
umls-concept:C0231174,
umls-concept:C0279025,
umls-concept:C0376358,
umls-concept:C0600558,
umls-concept:C0681842,
umls-concept:C0851346,
umls-concept:C1555582
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-7-18
|
|
pubmed:abstractText |
Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could be predicted by the rate of decline in the Hgb level following the administration of neoadjuvant AST or by the Hgb level at presentation or at the start of RT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10673
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
275-80
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12124826-Aged,
pubmed-meshheading:12124826-Aged, 80 and over,
pubmed-meshheading:12124826-Androgen Antagonists,
pubmed-meshheading:12124826-Antineoplastic Agents, Hormonal,
pubmed-meshheading:12124826-Chemotherapy, Adjuvant,
pubmed-meshheading:12124826-Combined Modality Therapy,
pubmed-meshheading:12124826-Hemoglobins,
pubmed-meshheading:12124826-Humans,
pubmed-meshheading:12124826-Male,
pubmed-meshheading:12124826-Middle Aged,
pubmed-meshheading:12124826-Multivariate Analysis,
pubmed-meshheading:12124826-Prognosis,
pubmed-meshheading:12124826-Prostate-Specific Antigen,
pubmed-meshheading:12124826-Prostatic Neoplasms,
pubmed-meshheading:12124826-Radiotherapy, Conformal,
pubmed-meshheading:12124826-Regression Analysis,
pubmed-meshheading:12124826-Testosterone
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. adamico@lroc.harvard.edu
|
|
pubmed:publicationType |
Journal Article
|
